Dasabuvir
Dasabuvir
Dasabuvir (pronounced: dah-sah-BYOO-vir) is a pharmaceutical drug used in the treatment of Hepatitis C. It is a non-nucleoside polymerase inhibitor that prevents the replication of the Hepatitis C virus by binding to the NS5B protein.
Etymology
The name "Dasabuvir" is derived from the drug's chemical structure. The prefix "Dasa-" is a reference to the drug's ten-membered ring structure, while "-buvir" is a common suffix for antiviral drugs that inhibit the NS5B protein.
Usage
Dasabuvir is used in combination with other antiviral drugs, such as ombitasvir, paritaprevir, and ritonavir, in a treatment regimen known as Viekira Pak. This combination therapy is used to treat chronic Hepatitis C infections in adults.
Side Effects
Common side effects of Dasabuvir include fatigue, headache, nausea, and insomnia. In rare cases, it can cause severe liver problems, especially in patients with pre-existing liver disease.
Related Terms
- Hepatitis C: A viral infection that causes liver inflammation, sometimes leading to serious liver damage.
- Polymerase inhibitor: A type of antiviral drug that prevents the replication of viral DNA or RNA.
- NS5B protein: A protein that is essential for the replication of the Hepatitis C virus.
- Viekira Pak: A combination therapy used to treat chronic Hepatitis C infections in adults.
External links
- Medical encyclopedia article on Dasabuvir
- Wikipedia's article - Dasabuvir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski